ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03517449
Brief Title: Lenvatinib in Combination With Pembrolizumab Versus Treatment of Physician's Choice in Participants With Advanced Endometrial Cancer (MK-3475-775/E7080-G000-309 Per Merck Standard Convention [KEYNOTE-775])

First Submitted : April 25, 2018
First Submitted that Met QC Criteria : April 25, 2018
First Posted : May 7, 2018

Last Update Submitted that Met QC Criteria : September 6, 2018
Last Update Posted : September 7, 2018